Several U.S. medical societies have collaborated on a new report advocating for better safety standards in cardiac catheterization labs. As one cardiologist described it, clinicians have shifted from "accepting risk" to "expecting better."

The new approach allows private practices to expand and evolve without being acquired.

The OmniaSecure defibrillation lead from Medtronic is already approved for placement in the right ventricle. This latest approval covers the left bundle branch area, opening the door for conduction system pacing and other advanced techniques.

Advanced AI software developed by Cleerly consistently produced plaque assessments comparable to intravascular ultrasound. 

Bringing in a new and improved cardiovascular IT system can save physicians a ton of time and lead to considerable cost savings.

Heartflow's AI technologies are at the center of multiple ACC.26 presentations. In addition, the company announced, the first patient was enrolled into the NAVIGATE-PCI registry.

CRT studies shed new light on many topics, including long-term TAVR outcomes, radiation protection and advanced interventional techniques.

The new device, which provides users with real-time images in full color, is now approved by the FDA to be used in the peripheral vasculature. Meanwhile, first-in-human data published in Stroke explored its potential in the cerebral vasculature.